We published our first review on Synthetic Biology based bacterial cancer therapies.

In this review we:

  • Proposal of a synthetic biology-based modular design for bacterial cancer therapies.

  • Identification of necessary modules and requirements for bacteria to be considered.
  • Recognition of limitations in current bacterial cancer therapies.
  • Aim to facilitate the development of new engineered bacteria against cancer.
  • Empowering to ensure no negative effects on the cancer patient or the environment.

Check the article in https://www.sciencedirect.com/science/article/pii/S1040842823001762